Studie on drug nonequivalence. X. Bioavailability of 6-mercaptopurine polymorphs. 1981

T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada

UI MeSH Term Description Entries
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D015122 Mercaptopurine An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. 6-Mercaptopurine,1,7-Dihydro-6H-purine-6-thione,6-Mercaptopurine Monohydrate,6-Thiohypoxanthine,6-Thiopurine,6H-Purine-6-thione, 1,7-dihydro-,BW 57-323H,Leupurin,Mecaptopurine Anhydrous,Mercaptopurina Wellcome,Puri-Nethol,Purimethol,Purinethol,6 Mercaptopurine,6 Mercaptopurine Monohydrate,6 Thiohypoxanthine,6 Thiopurine,BW 57 323H,BW 57323H

Related Publications

T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
June 1974, The Kobe journal of medical sciences,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
January 1989, The American journal of pediatric hematology/oncology,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
April 1987, Clinical pharmacology and therapeutics,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
April 1984, The New England journal of medicine,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
May 1988, Clinical pharmacology and therapeutics,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
September 2006, Pediatric hematology and oncology,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
May 1992, Pharmaceutical research,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
January 1964, Giornale di medicina militare,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
January 1967, Strahlentherapie,
T Yokoyama, and T Umeda, and K Kuroda, and T Kuroda, and S Asada
December 1954, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!